Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nikolaos F Pistamaltzian"'
Publikováno v:
Expert review of respiratory medicine. 13(5)
Cancer immunotherapy represents a major therapeutic breakthrough. Immune checkpoint inhibitors alone or in the context of a combination are considered the new standard of care in advanced non-small cell lung cancer (NSCLC). Areas covered: This review
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ec5d3e83d456faf8829370df7119979
https://pubmed.ncbi.nlm.nih.gov/30869543
https://pubmed.ncbi.nlm.nih.gov/30869543
Autor:
Charalampos Christofillakis, Konstantinos Kalbakis, Nikolaos F Pistamaltzian, Charalampos Kourousis, Dimitris Mavroudis, Aris Polyzos, Nikolaos Kentepozidis, Emmanouil Saloustros, Michail Nikolaou, L. Vamvakas, Vasilios Georgoulias
Publikováno v:
Clinical breast cancer. 18(1)
Background Triple-negative breast cancer (TNBC) lacks a standard targeted therapeutic strategy and is treated with conventional cytotoxic agents. Because of the sensitivity of TNBC to platinum compounds and the synergistic effect of bevacizumab with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16d4632bdddec0f7e8234705960ea415
https://pubmed.ncbi.nlm.nih.gov/29153775
https://pubmed.ncbi.nlm.nih.gov/29153775